GnRH analogues as a monotherapy in transgender and gender diverse adolescents: clinical insights from a single center study

CONCLUSION: GnRHa effectively suppressed sex hormone levels in adolescents with GD, although gonadotropin suppression was not complete, particularly in the Tanner 4/5 group, where gonadotropin levels remained elevated. Side effects were frequently reported, particularly in the Tanner 4/5 group, while the impact on pubertal development was limited. Therefore, the benefits and drawbacks of GnRHa treatment should be carefully considered, particularly in adolescents at Tanner stages 4 and 5.

via https://pubmed.ncbi.nlm.nih.gov/40622335/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20250721010906&v=2.18.0.post9+e462414